U-Blot® Research Grade DectrekumabCat. No. WA2668$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade DectrekumabCat. No. WA2668
U-Blot® Research Grade DazukibartCat. No. WA2667
U-Blot® Research Grade DaxdilimabCat. No. WA2666
U-Blot® Research Grade DavutamigCat. No. WA2665
U-Blot® Research Grade DavoceticeptCat. No. WA2664
U-Blot® Research Grade DatopotamabCat. No. WA2663
U-Blot® Research Grade DargistotugCat. No. WA2662
U-Blot® Research Grade daretabartCat. No. WA2661
U-Blot® Research Grade DaratumumabCat. No. WA2660
U-Blot® Research Grade DapirolizumabCat. No. WA2659
U-Blot® Research Grade DanvilostomigCat. No. WA2658
U-Blot® Research Grade DanburstotugCat. No. WA2657